Beijing and Jakarta are deepening cooperation on public health initiatives, with a particular focus on combating tuberculosis, exploring the potential of traditional medicines, and leveraging technological advancements to improve healthcare access and outcomes. The renewed commitment follows a meeting in Beijing on Friday between Indonesian Health Minister Budi Gunadi Sadikin and Lei Haichao, Head of China’s National Health Commission (NHC), signaling a strengthened partnership between the two nations in addressing shared health challenges.
Indonesia is looking to China’s experience in significantly reducing tuberculosis prevalence, a disease that remains a major public health concern globally. According to the World Health Organization, Indonesia has one of the highest TB burdens in the world, with an estimated 823,000 new cases in 2022. The WHO reports that TB remains the 13th leading cause of death worldwide.
Beyond tuberculosis, Sadikin highlighted the importance of digital transformation within healthcare systems and the potential of cutting-edge technologies like brain-computer interfaces. He also expressed appreciation for a Chinese fellowship program that has provided opportunities for 113 Indonesian doctors to receive training at hospitals across China over the past year, meeting with several participants during his visit. This exchange program underscores China’s growing role in international medical education and capacity building.
Expanding Collaboration on Key Health Priorities
The discussions in Beijing built upon existing agreements signed last year during a meeting between Indonesian President Joko Widodo and Chinese Premier Li Qiang. These initial agreements laid the groundwork for collaboration in three key areas: Chinese traditional medicine, tuberculosis management, and personnel exchange programs. The current talks aim to translate those agreements into concrete action plans and identify new avenues for cooperation.
Specifically, Indonesia is keen to learn from China’s advancements in utilizing artificial intelligence (AI) within the healthcare sector. Sadikin, speaking at the 2026 Zhongguancun Forum – an event hosted by Tsinghua University and the Chinese Academy of Engineering – argued that AI will not replace doctors, but that healthcare professionals who fail to embrace the technology risk falling behind. He emphasized the need for continuous learning and adaptation in the face of rapid technological change.
The Indonesian minister’s speech at the Zhongguancun Forum highlighted a growing global recognition of AI’s potential to revolutionize healthcare, from diagnostics and treatment planning to drug discovery and personalized medicine. However, ethical considerations and the need for robust data privacy safeguards remain crucial as AI becomes more integrated into healthcare systems.
Vaccine Development and Pharmaceutical Partnerships
Sadikin’s visit also yielded tangible results in the form of a new agreement between an Indonesian pharmaceutical company and China’s Sinovac Biotech. The deal focuses on collaborative vaccine development and production, potentially strengthening Indonesia’s capacity to respond to future pandemics and address vaccine-preventable diseases. Sinovac is a leading Chinese biopharmaceutical company known for its COVID-19 vaccine, CoronaVac.
This partnership reflects a broader trend of increased collaboration between Indonesia and China in the pharmaceutical sector. Indonesia, with its large population and growing healthcare needs, represents a significant market for Chinese pharmaceutical companies, while China offers Indonesia access to advanced manufacturing capabilities and research expertise.
Digital Health and Technological Innovation
The focus on digitalization within Indonesia’s healthcare system is driven by the country’s ambitious goal of achieving universal health coverage. Improving access to healthcare services, particularly in remote and underserved areas, requires leveraging technology to overcome geographical barriers and reduce costs. China’s experience in implementing large-scale digital health initiatives, such as mobile health apps and telemedicine platforms, is of particular interest to Indonesia.
The exploration of brain-computer interface technology, while still in its early stages, represents a more futuristic aspect of the collaboration. This technology has the potential to revolutionize the treatment of neurological disorders and improve the quality of life for patients with disabilities, but significant research and development are still needed.
Looking Ahead: A Joint Committee Meeting
To further solidify the health cooperation between Indonesia and China, Sadikin extended an invitation to NHC Head Lei to visit Indonesia for a joint committee meeting. The meeting is intended to foster greater synergy in addressing evolving challenges in the health sector and to develop a roadmap for future collaboration. No date for the meeting has been announced yet.
The deepening health partnership between Indonesia and China comes amid broader efforts to strengthen bilateral ties in areas such as trade, investment, and security. Recent reports indicate increased cooperation on security matters as well, reflecting a shared interest in maintaining regional stability.
Disclaimer: This article provides information about health cooperation between Indonesia and China and should not be considered medical advice. For health-related concerns, please consult with a qualified healthcare professional.
The outcomes of the upcoming joint committee meeting will be a key indicator of the long-term success of this health partnership. Continued dialogue and collaboration will be essential to address the complex challenges facing both countries and to improve the health and well-being of their populations. Share your thoughts on this developing story in the comments below.
